InsidersTradesSigma
Follow the 康缘药业 share price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 康缘药业 has published 6 reports. Market capitalisation: €7bn. The latest transaction was reported on 1 December 2025 (Purchase). Among the most active insiders: 刘权. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
康缘药业 es una empresa centrada en la investigación, desarrollo y fabricación de productos farmacéuticos. Cotiza en la Bolsa de Valores de Shanghái.